Painless liver scan could spot hidden damage in heavy drinkers with extra weight

NCT ID NCT06924281

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a quick, painless liver scan (Fibroscan®) to standard screening questions could better identify people at risk for liver disease caused by both alcohol and excess weight. Fourteen English- or Spanish-speaking adults from underserved communities took part. The goal was to see if this approach was practical and acceptable, not to provide a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STEATOTIC LIVER DISEASE OF MIXED ORIGIN (METALD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinica Esperanza Hope Clinic

    Providence, Rhode Island, 02909, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.